The HOPE Study: Testing a Non-invasive, Light and Sound Stimulation Treatment for Alzheimer’s

Join Cognito Therapeutics CEO, Brent Vaughan to talk about the pivotal HOPE Study, currently open for recruitment, which uses an investigational medical device consisting of headphones and eyewear to deliver sensory stimulation treatment in the comfort of people’s homes. The HOPE Study explores if this approach will potentially prove to slow the progression of mild to moderate Alzheimer’s disease.
Zoom In on Dementia & Alzheimer's is a monthly virtual discussion series with world-class expert research scientists to keep you informed about the latest breakthroughs and findings in the field-from treatments and genetics to risk reduction, and more.
#alzheimers #alzheimersawareness #alzheimersdisease #alzheimer #dementia #aging

[@SurYadi-ke6ro]

👍